SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing intense volatility as investors weigh firm underlying AI-driven demand against significant compounding risks, including heightened geopolitical tensions, potential rate hikes, and growing concerns over the ROI on hyperscaler capital expenditures. The community remains deeply divided, with many traders debating whether recent sharp pullbacks represent a structural shift in the chip sector or a temporary buying opportunity driven by market-maker liquidations ahead of major big-tech earnings.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heightened activity as market participants clash over conflicting narratives, with some traders highlighting strong earnings and potential long-term AI foundry demand, while others react to broader sector sell-offs and concerns over capital expenditure cycles. The stock remains a major point of contention, with intense community debate occurring between long-term investors pointing to fundamental growth and bears focusing on technical breakdowns and perceived institutional manipulation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a sharp stock price decline following FDA briefing documents that challenged the company's statistical analysis plan (SAP) for its Duchenne muscular dystrophy drug. The community is actively debating whether the FDA mistakenly relied on an obsolete internal draft instead of the final version or if the company engaged in post-hoc data manipulation ahead of the upcoming advisory committee meeting.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors await its fiscal fourth-quarter earnings report, with community sentiment split between high-conviction bulls pointing to strong contract backlogs and bear-case concerns regarding capital intensity and share dilution. Discussions are heavily focused on the company's ability to demonstrate profitable execution amid a broader market rotation and skepticism toward AI infrastructure spending.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors closely watch for potential global expansion announcements teased by leadership for July, with heightened attention surrounding the company's participation in the virtual BTIG Biotechnology Conference. Community discussion centers on frustration over timing and lack of news, countered by bullish sentiment from long-term investors who remain focused on the company's oncology pipeline and the possibility of a short squeeze.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging following a strong quarterly earnings report that significantly beat expectations and featured a raised full-year outlook driven by accelerating demand for AI server infrastructure. While the broader semiconductor sector has faced volatility, investors remain highly focused on Celestica's role as a key manufacturing partner for major hyperscalers, with active community discussion centering on whether the company's aggressive growth guidance for future years can sustain current valuation premiums.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package and International Package. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is currently trending as investors react to increased competitive pressure from Amazon's expanded logistics and supply chain services. Market sentiment is heavily focused on the stock's recent price volatility, the long-term impact of its union labor costs, and the appeal of its dividend yield as the company navigates ongoing operational restructuring.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Royal Caribbean is surging on the back of exceptionally strong forward guidance and record-breaking booking momentum that has overshadowed a slight earnings miss. Investors and the community are actively debating the stock's resilience, with many highlighting its dominant position and premium pricing power within the travel sector.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is trending as the stock navigates a significant restructuring plan aimed at long-term efficiency, even as investors remain focused on the company's upcoming earnings report. The community is actively debating whether the current pullback represents a deep-value buying opportunity or a signal of structural weakness, while many monitor institutional accumulation and the potential for a sector rotation into medical technology.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF (EWY) is currently trending due to intense investor focus on the South Korean semiconductor and memory chip sector, fueled by surging demand for AI-driven High Bandwidth Memory. Market participants are actively discussing the heavy concentration of Samsung and SK Hynix within the index, debating whether the rapid valuation gains represent a sustainable structural shift or an overextended speculative bubble driven by excessive retail leverage.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
